Sunresin Establishes Subsidiary in Sweden to Strengthen Global Life Sciences Strategy
Sunresin is pleased to announce the establishment of its new subsidiary and European Regional Headquarters for Life Sciences in Sweden. This important step marks a major advancement in the company’s global expansion and its long-term commitment to serving the international biopharmaceutical and biotechnology markets.
As part of this strategic move, Sunresin has appointed Mr. Hans Johansson—a well-respected expert in chromatography and bioprocessing—as the General Manager, responsible for the overall operations and strategic development of the region.

Industry Expertise Strengthening Global Competitiveness
Mr. Hans Johansson brings more than 35 years of experience in separation technologies and bioprocessing. He has held senior scientific and leadership positions at globally recognized companies such as GE Healthcare and Ecolab Life Sciences.
Throughout his career, he has made significant contributions to the advancement of purification technologies for monoclonal antibodies, vaccines, and other biologics. His extensive background in developing adsorption and chromatography materials for large-molecule bioprocessing will play a pivotal role in accelerating Sunresin’s Life Sciences innovation and global growth.
Strategic Presence in a World-Class Life Sciences Hub
Sunresin’s Swedish subsidiary is located in one of Europe’s most important life sciences innovation clusters, an area known for cutting-edge research, industry collaboration, and strong talent resources.
The establishment of this office represents:
- A deeper commitment to serving the European biopharmaceutical and biotechnology ecosystem
- A strengthened connection to global scientific and technological frontiers
- A solid foundation for expanding Sunresin’s Life Sciences business internationally

Accelerating Expansion of Life Sciences Business in Europe
As Sunresin’s regional headquarters for Life Sciences, the Swedish subsidiary will:
- Drive and execute the company’s strategic initiatives in Europe
- Strengthen collaboration with local biopharmaceutical and biotech companies
- Enhance customer engagement through localized technical support and services
- Promote Sunresin’s advanced chromatography resins, purification materials, and system solutions across Europe
By integrating regional talent, technological expertise, and market opportunities, the new subsidiary will significantly enhance Sunresin’s brand presence and market competitiveness in Europe’s high-end bioprocessing sector.
Free Quote
Resources
Adsorbent Resin
Bio-Pharmaceutical & Life Science
Enzyme Carriers
Hydrometallurgy & Mining
Chelating Resin
Chemical Industry
Chromatographic Media
Wastewater Treatment&Reuse
Food & Beverage Industries
Ion Exchange Resin
Civil & Industry Water Treatment
Equipments And Projects
Plant Extraction
Catalyst Resin
Solid Phase Peptide Synthesis
Product
Application
Contact Us
Sunresin Park,No.135, jinye Road, Xi’an Hi-tech Industrial Development Zone, Shaanxi-710076, China
seplite@sunresin.com
seplite_europe@sunresin.com
+86-29-89182091
Our Product List
Latest News
26
2025 11
Sunresin Establishes Subsidiary in Sweden to Strengthen Global Life Sciences Strategy
Sunresin is pleased to announce the establishment of its new subsidiary and European Regional Headquarters for Life Sciences in Sweden.
01
2025 07
Sunresin Bioprocess Materials Achieve DMF Registration, Supporting Global Biopharma Compliance
Sunresin has obtained 10 Drug Master File (DMF) registrations for its chromatography resins used in antibody, vaccine, and gene therapy production. With 9 more products under review, Sunresin provides robust regulatory support for global pharmaceutical customers and accelerates IND/NDA filing efficiency with FDA and EMA compliance.
Leave a Message
Please send any questions you want to know, we will reply to you immediately.
Choose File
Submit